SMAD4 and adenoma: Within 24 h of TGF-β1 administration, > 90% of the Smad4+/+ adenoma cells either had either morphological changes of apoptosis with organoid retraction, or changes in shape toward a spindle or mesenchymal phenotype (see Supplementary Movies 1–4).